Fundraising FoxSarsia Management AS
Venture capitalBergen · Seed–Series A · 14 people tracked
Find your way into Sarsia Management AS
Each arrow is one introduction. Sign up to fill in the first one.
Ask Erik Langaker to introduce you to Hilde Holdhus
You →Erik · together at StormGeo →Hilde
Ask Jamie Chen to introduce you to Jon-Kåre Hansen
You →Jamie · together at Elekt AS →Jon-Kåre
Ask Sam Okafor to introduce you to Jon Trygve Berg
You →Sam · together at Norges Handelshøyskole (NHH) →Jon
- Sveinung Hole180 people can intro you
- Henrik Solberg-Johansen137 people can intro you
- Erlend Skagseth131 people can intro you
Sign up to find every way you can get introduced to Sarsia Management AS
- Your email: who you already know at Sarsia Management AS, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Sarsia Management AS team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
Sarsia is an early-stage venture capital firm investing across two main areas: life sciences, targeting unmet medical needs where capital and expertise can turn laboratory research into effective patient treatments; and technology, energy and sustainability, backing founders and technologies that can accelerate the green transition and build sustainable companies. The firm emphasizes technologies that improve quality of life and society while reducing negative environmental impact, connecting strong science and solutions with competent capital. Drawing on a team with diverse backgrounds and perspectives, Sarsia takes on risk to create value and is one of the top-performing early-stage venture funds in the Nordic region.
Source: firm website, verified Aug 3, 2026.
Team · 14 people
from the firm's website & curated & public directories
What they invest in
from 14 of 49 portfolio companiesBiotech ×7Healthtech ×7Medical Devices ×4AI & Machine Learning ×3Cleantech ×3Energy ×3Hardware ×3Climate Tech ×2
HQs:Norway×8Finland×1Sweden×1United States×1
Investments · 49 tracked
founders shown can be your intro pathAPIM Therapeutics is a clinical-stage oncology company developing first-in-class PCNA-targeting peptide therapeutics that disrupt cellular stress responses and address treatment resistance in cancer.
BiotechHealthtech
Co-investorsBirk Venture
BerGenBio ASA was a company that merged with Oncoinvent ASA on 29 October 2025, with the combined entity renamed Oncoinvent.
Biotech
Co-investorsBirk VentureInvestinor
Caedo Oncology develops therapeutic antibodies for cancer treatment, leveraging deep immunology and antibody engineering expertise.
BiotechHealthtechLongevityMedical DevicesOslo, NO
Kjetil Hestdal(Co-founder and CEO)
Co-investorsFarvatn VenturePlanet 9 Capital
Completed patient enrollment in its Phase 2 AURORA trial.
Co-investorsP53 InvestForbionInvestinor
Co-investorsBackingMindsImpact VenturesShift4Good
Coegin Pharma develops and commercializes advanced cosmetic peptide technologies for hair and skin care, targeting the global longevity and wellness market.
BiotechConsumerHealthtechWellness & FitnessLund, SE
Co-investorsVentac Partners
Elekt provides a white-label customer platform for electricity and grid utilities, including a consumer app, a business portal, and a CRM/marketing hub for the utility's own team.
EnergyEnterprise SoftwareSaaS
Arnt Inge Sætern(Founder)in
Flow Computing develops the Flow PPU (Parallel Processing Unit), a licensable on-die parallel co-processor architecture that works alongside CPUs to improve parallel throughput and scalability.
Deep TechHardwareSemiconductorsHelsinki, FI
Timo Valtonen(Founder)inMartti Forsell(Founder)Jussi Roivainen(Founder)in
Co-investorsButterfly VenturesSuperhero Capital8VCButterflyMVP VenturesNeo+5 more
Heimdall Power develops advanced sensors and software to enhance power grid visibility, safety, and responsiveness for grid operators globally.
AI & Machine LearningCleantechEnergyIoTCharlotte, US
Jørgen Festervoll(CEO)in
Co-investorsEviny VenturesSprettertInvestinorORLEN VC
Nisonic develops FAST-ICP software that uses transorbital ultrasound imaging and machine learning to non-invasively detect raised intracranial pressure by measuring optic nerve sheath properties.
AI & Machine LearningHealthtechMedical DevicesTrondheim, NO
Co-investorsHadean VenturesInvestinor
Oculaudio develops hearing aids designed for aesthetic appeal and user-friendliness, targeting people with hearing loss who experience fatigue from concentration required in daily listening situations.
AI & Machine LearningHardwareHealthtechMedical Devices
Pacertool develops the PaCRTool-System, a medical device platform and single-use PreSens-Catheter that measures a proprietary electromechanical biomarker during pacemaker implantation to assess and optimize cardiac resynchronization therapy (CRT).
BiotechDigital HealthHardwareHealthtechMedical DevicesOslo, NO
Hans Henrik Odland(Founder)inMona K. Berg(Daglig leder / CEO)Hans Petter Tjeldflaat(Chief Financial Officer (CFO))Mohammad Albatat(Founder)Per Magne Florvaag(Founder)
Co-investorsFarvatn VenturePlanet 9 Capital
Pluvia Biotech is a University of Bergen spin-out developing small molecule pharmacological chaperones that stabilize and correct misfolded proteins to rescue enzymatic activity in rare genetic loss-of-function disorders.
BiotechDeep TechHealthtechBergen, NO
Aurora Martinez(CTO)Willem van Weperen(CEO)Torgeir Vaage(CFO)in
Co-investorsInvestinor
Soiltech provides treatment, recycling, and disposal solutions for contaminated water and industrial waste across energy, aquaculture, and municipal sectors.
Circular EconomyCleantechClimate TechNorway, NO
Co-investorsGreat North VenturesHomegrown CapitalInnova Memphis, Inc.
High accuracy clamp-on flow rate and phase fraction meter for gas, oil, water and drilling mud systems.
Co-investorsProVenture
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AquilozBlue LimitC10 PharmaChargitectDelante HealthEnsoEnuaFlow ComputingGenesequeGreen Power HubHepmarinInsentioKeelspotMedstorm Innovation AsMitigrateMovelOffshore SensingProphylix Pharma AsQbeeScandinavian BiopharmaScreencancer AsSea Hawk Navigation AsSeafarm Solutions AsSeasmartSerca PharmaceuticalsSonoClear ASSorbwater AsTrisense AsVaccibody AsVestland Pharma ASVolusenseWeylandWindsim As
Frequently asked questions
- How many investments has Sarsia Management AS made?
- Sarsia Management AS has 49 tracked investments.
- What stage does Sarsia Management AS invest at?
- Sarsia Management AS invests at the Seed, Series A stages.
- What is Sarsia Management AS's typical check size?
- Sarsia Management AS typically writes checks of $190K – $475K.
- What sectors does Sarsia Management AS focus on?
- Sarsia Management AS focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Hardware, Healthtech, IoT, Medical Devices, New Materials, Semiconductors.
- Where is Sarsia Management AS located?
- Sarsia Management AS is headquartered in Bergen, NO.
- Does Sarsia Management AS lead rounds?
- Yes, Sarsia Management AS leads investment rounds.
- Who does Sarsia Management AS co-invest with?
- Sarsia Management AS most often shares deals with Birk Venture, Farvatn Venture, BackingMinds, among 11 tracked co-investors.
Similar investors
Qbic is an inter-university venture capital fund that backs the transformation of technological breakthroughs from its academic and research partners into sustainable businesses.
Everywhere Ventures is an early-stage venture firm that writes pre-seed checks and is backed by a community of founder and operator LPs.
Asahi Kasei Corporate Venture Capital is the corporate venture arm of Asahi Kasei, a diversified Tokyo-based company, investing in innovative global startups in areas of strategic importance across materials, homes, and healthcare.
Range is a venture capital firm that invests in founders building novel solutions in overlooked or challenging categories. The firm focuses on consensus founders with unique insights, backing companies at various stages across diverse sectors.
Cowin Capital Group is a Chinese investment management firm with extensive experience investing in and exiting technology, healthcare, and industrial companies, many of which have gone public on Chinese and Hong Kong exchanges.